The GLR1.3 antibody is a specialized tool used to detect and study the glutamate receptor-like protein 1.3 (GLR1.3), a member of the ionotropic glutamate receptor family. These receptors play critical roles in neurotransmission in animals and stress responses in plants. Antibodies targeting GLR1.3 enable researchers to investigate its expression, localization, and function in diverse biological contexts, from neurological disorders to plant cold tolerance mechanisms .
In mammals: GLR1.3 (also termed GluA3 or GluR3) is a subunit of AMPA-type glutamate receptors, which mediate fast synaptic signaling in the central nervous system. It contains extracellular ligand-binding domains, transmembrane regions, and intracellular C-terminal domains involved in trafficking .
In plants: Arabidopsis thaliana GLR1.3 (AtGLR1.3) is a homolog of animal glutamate receptors, implicated in jasmonate signaling and cold stress responses .
The GLR1.3 antibody (e.g., Alomone Labs #AGC-010) targets an extracellular epitope of the rat GluR3 subunit, corresponding to residues 60–73 (CEKPFHLNYHVDHLD) . Its specificity has been validated in:
Autoantibodies against GluR3 (GLR1.3) are implicated in Rasmussen’s encephalitis, a rare pediatric autoimmune disorder characterized by severe epilepsy and brain inflammation :
Key evidence: Immunization of rabbits with GluR3 protein induced seizure-like behaviors and histopathological features resembling Rasmussen’s encephalitis .
Clinical relevance: Plasma exchange in patients reduced GluR3 antibody titers and improved neurological function transiently .
In Arabidopsis, AtGLR1.3 regulates cold tolerance through jasmonate signaling:
Preabsorption assays: Preincubation with GluR3 blocking peptide abolishes signal in Western blots and immunohistochemistry .
Cross-reactivity: The antibody shows no reactivity with unrelated glutamate receptor subunits (e.g., GluR1 or GluR2) .
Sample preparation: Use fresh or frozen tissues (e.g., rodent cerebellum) for optimal antigen preservation .
Dilution optimization: Typical working dilutions range from 1:400 (Western blot) to 1:100 (immunohistochemistry) .
Data quantification: Normalize signals using housekeeping proteins (e.g., β-tubulin) to account for loading variability .
Antibodies targeting GLR1.3 (Glutamate Receptor 1.3) require meticulous experimental design and validation to ensure research reproducibility. Below are structured FAQs addressing key methodological challenges in academic research contexts:
Method: Perform knockout controls using CRISPR/Cas9-edited cell lines or siRNA knockdown. Compare bands in wild-type vs. modified samples. Include lysates from tissues with known GLR1.3 expression (e.g., neuronal tissues) as positive controls .
Critical step: Run a secondary antibody-only control to rule out nonspecific binding.
Protocol:
Troubleshooting table:
Analysis framework:
Strategy:
Titration approach:
Approach:
Validation matrix:
| Potential Cross-Reactivity | Control Experiment |
|---|---|
| Related glutamate receptors (GLR1.1/1.2) | Lysates from cells expressing homologous proteins |
| Non-neuronal tissues | Test antibody in tissues with confirmed GLR1.3 absence |
| Species specificity | Compare reactivity in human vs. rodent protein arrays |